Skip to Main Content

Paper Details

Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy.
Adv Sci (Weinh)
2
2023
5-hydroxymethylcytosine, 5hmC, AML, AZA, Azacitidine, DNA methyltransferase, Granulocyte-macrophage-progenitor-like (GMP-like) malignant cells, Mito, Patients, acute myeloid leukemia, cytarabine, high-, mitoxantrone, natural, natural killer (NK) cells, patients, transcriptome
Author NameAffiliation
Chuan HeDepartment of Chemistry and Institute for Biophysical Dynamics, The University of Chicago
Chuan HeHoward Hughes Medical Institute
Chuan HeThe University of Chicago
Chuan HeDepartment of Chemistry and Institute for Biophysical Dynamics, The University of Chicago
Chuan HeHoward Hughes Medical Institute
Chuan HeThe University of Chicago
  • 1 - 6

Datasets

Release 1.2